Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

NEOGENOMICS, INC.

(NEO)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur NEOGENOMICS, INC.
19/01NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
19/01Neogenomics, Inc. Announces Resignation of Kevin Johnson from Board of Directors
11/01NeoGenomics Unit Receives CE Mark for Its RaDaR Liquid Biopsy Assay
11/01NEOGENOMICS : Announces RaDaR(TM) Assay Receives CE Mark and is Submitted for US Reimburse..
2021NeoGenomics Appoints David Eberhard Chief Medical Officer for Inivata
2021NEOGENOMICS : Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid B..
2021NEOGENOMICS : to Leverage Thermo Fisher Scientific's Ion Torrent Genexus System in Upcomin..
2021NEOGENOMICS : To Participate In The Stephens Annual Investment Conference 2021
2021INSIDER SELL : Neogenomics
2021NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
2021NeoGenomics, Inc. Appoints William Bonello as Chief Financial Officer, Effective Januar..
2021NeoGenomics, Inc. Appoints Kathryn Mckenzie as Chief Sustainability and Risk Officer, E..
2021NeoGenomics, Inc. Appoints Dave Daly to Its Board of Directors
2021NeoGenomics Appoints Dave Daly to Its Board of Directors
2021Genetron Holdings, NeoGenomics to Collaborate to Provide China-Based Medical Research S..
2021Genetron Health Establishes Strategic Partnership with NeoGenomics to Drive Global Onco..
2021Genetron Holdings Limited Establishes Strategic Partnership with NeoGenomics, Inc. to D..
2021NeoGenomics Names William Bonello Finance Chief
2021NEOGENOMICS : Q3 Earnings Snapshot
2021NeoGenomics Q3 Revenue Falls; Revises 2021 Outlook; Shares Down Pre-Bell
2021NeoGenomics Reports Revenue of $121 Million in the Third Quarter - Form 8-K
2021NeoGenomics, Inc. Revises Earnings Guidance for Full-Year 2021
2021Earnings Flash (NEO) NEOGENOMICS Reports Q3 Revenue $121.3M, vs. Street Est of $125.1M
2021Earnings Flash (NEO) NEOGENOMICS Reports Q3 Loss $-0.08, vs. Street Est of $-0.09
2021NeoGenomics Reports Revenue of $121 Million in the Third Quarter
2021NeoGenomics Announces Leadership Team Transition
2021NORTH AMERICAN MORNING BRIEFING : Stocks Futures -3-
2021NEOGENOMICS : Subsidiary Enters Into Clinical Trial Collaboration With Princess Margaret C..
2021NEOGENOMICS' : Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Prin..
2021Health Care Stocks Moderate Slightly in Afternoon Trading
2021NEOGENOMICS : Shares Rise After Raymond James Upgrade
2021Health Care Stocks Keeping Pace With Rising Thursday Markets
2021NEOGENOMICS : Schedules its Third Quarter 2021, Earnings Release for November 4, 2021
2021NEOGENOMICS : Appoints Lead Independent Director Lynn Tetrault as Non-Executive Chair. Dou..
2021NEOGENOMICS INC : Change in Directors or Principal Officers, Financial Statements and Exhi..
2021NeoGenomics, Inc. Announces Board Changes
2021NEOGENOMICS : Announces Board of Directors' Transition
2021Health Care Stocks Broadly Higher Late Friday
2021Guardant Health Reportedly Exploring an Acquisition of NeoGenomics
2021MARKET CHATTER : Guardant Health's Shares Sink on Reports of NeoGenomics Takeover Plans; S..
2021GUARDANT HEALTH : Reportedly Mulls Acquisition of Diagnostics Services Provider NeoGenomic..
2021GUARDANT HEALTH SAID TO WEIGH TAKEOV : Bloomberg
2021PANAKES PARTNERS : Rob Woodman a capo degli investimenti biotech
2021NEOGENOMICS' : Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Fur..
2021NEOGENOMICS : to Participate in the Morgan Stanley 19th Annual Global Healthcare Conferenc..
2021INSIDER TRENDS : NeoGenomics Insider Sells for Tax Adds to 90-Day Selling Trend
2021NEOGENOMICS INC : Regulation FD Disclosure (form 8-K)
2021NEOGENOMICS : Q2 Earnings Snapshot
2021NEOGENOMICS : Q2 Net Loss Narrows, Revenue Rises, Reiterates Guidance; Shares Edge Higher ..
2021NeoGenomics Seeks M&A
2021NEOGENOMICS INC : Results of Operations and Financial Condition (form 8-K)
2021NeoGenomics, Inc. Reiterates Consolidated Earnings Guidance for the Year 2021
2021NEOGENOMICS : Earnings Flash (NEO) NEOGENOMICS Reports Q2 Loss $-0.01
2021NEOGENOMICS : Earnings Flash (NEO) NEOGENOMICS Reports Q2 Revenue $121.7M
2021GUIDANCE : (NEO) NEOGENOMICS Forecasts Fiscal Year 2021 Revenue Range $490M - $510M
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
2021NEOGENOMICS : Schedules its Second Quarter 2021 Earnings Release for August 6, 2021
2021NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
2021NeoGenomics, Inc. Appoints George A. Cardoza as President and Chief Operating Officer, ..
2021NEOGENOMICS INC : Completion of Acquisition or Disposition of Assets (form 8-K)
2021NeoGenomics, Inc. Announces Appointment of Clive Morris as President
2021NEOGENOMICS : Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Techno..
2021NEOGENOMICS : Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Techno..
2021NEOGENOMICS INC : Other Events (form 8-K)
2021NEOGENOMICS : Insider Makes Significant Stock Sells in NeoGenomics (NEO) Shares
2021INSIDER TRENDS : NeoGenomics Insider Extends 90-Day Selling Trend
2021NEOGENOMICS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
2021NEOGENOMICS : To Participate Virtually In Multiple Upcoming Institutional Investor Confere..
2021NEOGENOMICS : To Participate In The Bank of America 2021 Health Care Conference
2021NEOGENOMICS INC : Regulation FD Disclosure (form 8-K)
2021NEOGENOMICS : Q1 Earnings Snapshot
2021NEOGENOMICS : Investor Presentation – May 2021
2021NEOGENOMICS : Inivata Special Presentation
2021NEOGENOMICS : Conference Call Presentation
2021NEOGENOMICS' : Q1 Loss Widens, Revenue Rises
1  2  3  4Suiv.
Prochain événement sur NEOGENOMICS, INC.